You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer
|
|---|---|
| Published in |
Expert Opinion on Drug Safety, November 2023
|
| DOI | 10.1080/14740338.2023.2288147 |
| Pubmed ID | |
| Authors |
Ilana Schlam, Antonio Giordano, Sara M. Tolaney |
X Demographics
The data shown below were collected from the profiles of 47 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 15 | 32% |
| Mexico | 4 | 9% |
| Italy | 3 | 6% |
| Japan | 2 | 4% |
| Poland | 1 | 2% |
| Brazil | 1 | 2% |
| Pakistan | 1 | 2% |
| Uruguay | 1 | 2% |
| Vietnam | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 15 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 49% |
| Practitioners (doctors, other healthcare professionals) | 16 | 34% |
| Scientists | 8 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2024.
All research outputs
#1,533,680
of 25,554,853 outputs
Outputs from Expert Opinion on Drug Safety
#51
of 1,292 outputs
Outputs of similar age
#23,821
of 358,325 outputs
Outputs of similar age from Expert Opinion on Drug Safety
#2
of 21 outputs
Altmetric has tracked 25,554,853 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,292 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,325 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.